Cancer Biology & Therapy
Volume 23, 2022 - Issue 1
Review
Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome
Kristi Y. LeeMolecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
https://orcid.org/0000-0002-6228-4972View further author information
https://orcid.org/0000-0002-6228-4972View further author information, , & William D. FiggMolecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
https://orcid.org/0000-0003-2428-5613View further author information
https://orcid.org/0000-0003-2428-5613View further author information